| 4614- | SSE, | Rad, | Updates on clinical studies of selenium supplementation in radiotherapy |
| - | Review, | Nor, | NA |
| 1706- | SSE, | Selenium in Prostate Cancer: Prevention, Progression, and Treatment |
| - | Review, | Pca, | NA |
| 1707- | SSE, | A Diet Lacking Selenium, but Not Zinc, Copper or Manganese, Induces Anticancer Activity in Mice with Metastatic Cancers |
| - | in-vivo, | Ovarian, | NA | - | in-vivo, | BC, | NA |
| 1697- | SSE, | Calc, | Calcium intake may explain the reduction of colorectal cancer odds by dietary selenium - a case-control study in Poland |
| - | Human, | CRC, | NA |
| 1688- | SSE, | Potential Role of Selenium in the Treatment of Cancer and Viral Infections |
| - | Review, | Var, | NA |
| 1687- | SSE, | Selenium for preventing cancer |
| - | Analysis, | Var, | NA |
| - | in-vitro, | NSCLC, | A549 |
| 112- | SuD, | Inhibition of Gli/hedgehog signaling in prostate cancer cells by “cancer bush” Sutherlandia frutescens extract |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP |
| 4215- | SY, | Safflower yellow alleviates cognitive impairment in mice by modulating cholinergic system function, oxidative stress, and CREB/BDNF/TrkB signaling pathway |
| - | in-vivo, | NA, | NA |
| 4151- | Taur, | Gins, | Taurine and Ginsenoside Rf Induce BDNF Expression in SH-SY5Y Cells: A Potential Role of BDNF in Corticosterone-Triggered Cellular Damage |
| - | in-vitro, | AD, | NA |
| 4157- | Taur, | Antidepressant dose of taurine increases mRNA expression of GABAA receptor α2 subunit and BDNF in the hippocampus of diabetic rats |
| - | in-vivo, | AD, | NA |
| 3966- | Taur, | The Effects of Dietary Taurine-Containing Jelly Supplementation on Cognitive Function and Memory Ability of the Elderly with Subjective Cognitive Decline |
| - | Human, | AD, | NA |
| 3965- | Taur, | Taurine-Related Nutritional Knowledge Has a Positive Effect on Intake of Taurine and Cognitive Function in the Elderly |
| - | Human, | AD, | NA |
| 3964- | Taur, | Comparison of Urinary Excretion of Taurine Between Elderly with Dementia and Normal Elderly |
| - | Human, | AD, | NA |
| 3963- | Taur, | Past Taurine Intake Has a Positive Effect on Present Cognitive Function in the Elderly |
| - | Human, | AD, | NA |
| 3962- | Taur, | The Development of Taurine Supplementary Menus for the Prevention of Dementia and Their Positive Effect on the Cognitive Function in the Elderly with Dementia |
| - | Human, | AD, | NA |
| 3961- | Taur, | Effects of Dietary Taurine Supplementation on Blood and Urine Taurine Concentrations in the Elderly Women with Dementia |
| - | Human, | AD, | NA |
| 3960- | Taur, | Versatile Triad Alliance: Bile Acid, Taurine and Microbiota |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 3959- | Taur, | Taurine Directly Binds to Oligomeric Amyloid-β and Recovers Cognitive Deficits in Alzheimer Model Mice |
| - | in-vivo, | AD, | NA |
| 3958- | Taur, | Evaluation of the neuroprotective effect of taurine in Alzheimer’s disease using functional molecular imaging |
| - | in-vivo, | AD, | NA |
| 3957- | Taur, | Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases |
| 3955- | Taur, | Mechanism of neuroprotective function of taurine |
| - | in-vitro, | NA, | NA |
| 3967- | Taur, | The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis |
| - | Review, | Nor, | NA |
| - | in-vivo, | AD, | NA |
| 3950- | Taur, | Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes |
| - | Review, | Diabetic, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 3951- | Taur, | Taurine Supplementation Alleviates Blood Pressure via Gut–Brain Communication in Spontaneously Hypertensive Rats |
| - | in-vivo, | NA, | NA |
| 3952- | Taur, | Taurine and Astrocytes: A Homeostatic and Neuroprotective Relationship |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 3953- | Taur, | Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons |
| - | in-vitro, | AD, | NA |
| 3956- | Taur, | Mechanisms underlying taurine protection against glutamate-induced neurotoxicity |
| - | Review, | AD, | NA |
| 3954- | Taur, | Mode of action of taurine as a neuroprotector |
| - | in-vitro, | AD, | NA |
| 1137- | Taur, | Taurine Attenuates Epithelial-Mesenchymal Transition-Related Genes in Human Prostate Cancer Cells |
| - | in-vitro, | Pca, | NA |
| 1051- | Taur, | immuno, | Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell function |
| - | in-vivo, | Lung, | NA |
| 1202- | Tb, | The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells |
| - | in-vitro, | Ovarian, | NA |
| 5339- | TFdiG, | Pre-treated theaflavin-3,3′-digallate has a higher inhibitory effect on the HCT116 cell line |
| - | in-vitro, | CRC, | HCT116 |
| 5338- | TFdiG, | Isolation and antioxidant characterization of theaflavin for neuroprotective effect in mice model |
| - | in-vivo, | Nor, | NA |
| 5337- | TFdiG, | Theaflavin 3,3'-digallate suppresses metastasis and reduces insulin-like growth factor-1-induced cancer stemness and invasiveness in human melanoma cells |
| - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Melanoma, | A2058 |
| 5336- | TFdiG, | Theaflavin-3,3′-Digallate Protects Cartilage from Degradation by Modulating Inflammation and Antioxidant Pathways |
| - | in-vivo, | Nor, | NA |
| 5327- | TFdiG, | Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells |
| - | in-vitro, | Ovarian, | A2780S |
| 5328- | TFdiG, | Study on mechanism of low bioavailability of black tea theaflavins by using Caco-2 cell monolayer |
| - | in-vitro, | NA, | Caco-2 |
| 5329- | TFdiG, | The Microbiota Is Essential for the Generation of Black Tea Theaflavins-Derived Metabolites |
| - | Human, | Nor, | NA |
| 5330- | TFdiG, | Cisplatin, | Theaflavin-3,3′-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | OVCAR-3 |
| 5331- | TFdiG, | Anti-Cancer Properties of Theaflavins |
| - | Review, | Var, | NA |
| 5332- | TFdiG, | Theaflavin-3,3′-digallate triggers apoptosis in osteosarcoma cells via the caspase pathway |
| - | vitro+vivo, | OS, | 143B | - | in-vitro, | OS, | U2OS |
| 5333- | TFdiG, | Theaflavin-3,3′-Digallate Plays a ROS-Mediated Dual Role in Ferroptosis and Apoptosis via the MAPK Pathway in Human Osteosarcoma Cell Lines and Xenografts |
| - | vitro+vivo, | OS, | MG63 |
| 5334- | TFdiG, | Theaflavin inhibits the malignant phenotype of human anaplastic thyroid cancer 8305C cells by regulating lipid metabolism via PI3K/AKT signaling |
| - | in-vitro, | Thyroid, | 8505C |
| 5335- | TFdiG, | Microbial Metabolism of Theaflavin-3,3′-digallate and Its Gut Microbiota Composition Modulatory Effects |
| - | in-vivo, | Nor, | NA |
| 2373- | TMZ, | The role of pyruvate kinase M2 in anticancer therapeutic treatments |
| - | Review, | Var, | NA |
| 139- | Tomatine, | CUR, | Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells |
| - | in-vitro, | Pca, | PC3 |
| 113- | TQ, | Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer |
| - | vitro+vivo, | Pca, | C4-2B |
| 962- | TQ, | Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways |
| - | in-vitro, | PC, | PANC1 | - | in-vitro, | Nor, | hTERT-HPNE | - | in-vitro, | PC, | AsPC-1 | - | in-vitro, | PC, | Bxpc-3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid